Sol-Gel Technologies Ltd.
No enriched coverage for $SLGL in the last 7 days.
Opaleye Management Inc. purchased 3,124 indirectly-held shares of Sol-Gel Technologies Ltd. (SLGL) at an average of $66.39 ($65.94–$66.80, $0.21M total) across 2 trades over 2026-09-10 to 2026-09-11.
Opaleye Management Inc. purchased 9,976 indirectly-held shares of Sol-Gel Technologies Ltd. (SLGL) at an average of $68.88 ($68.70–$69.52, $0.69M total) across 5 trades over 2026-09-04 to 2026-09-09.
Opaleye Management Inc. purchased 1,683 indirectly-held shares of Sol-Gel Technologies Ltd. (SLGL) at an average of $69.21 ($68.95–$69.52, $0.12M total) across 2 trades over 2026-09-01 to 2026-09-02.
Recent SLGL coverage spans insider activity, earnings and market movers.
In the last 30 days, SLGL insiders filed 14 SEC Form 4 transactions — 14 purchases ($3.8M) and no sales. The most active reporter was Opaleye Management Inc. with 14 filings.
Small insider purchase likely reflects confidence but unlikely to move the stock materially.
The insider purchase signals confidence from a 10% owner, modestly bullish for SLGL.
Small insider purchase; unlikely to move price materially.
Insider buying by a significant shareholder may signal confidence, modestly supporting the stock.
Quarterly revenue collapse and trial progress may pressure the stock short‑term, but continued Phase 3 data could support upside.
AlphAI scores every news story that mentions SLGL with an AI model for sentiment and relevance, and aggregates insider trades from Sol-Gel Technologies Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Opaleye Management Inc. purchased 3,124 indirectly-held shares of Sol-Gel Technologies Ltd. (SLGL) at an average of $66.39 ($65.94–$66.80, $0.21M total) across 2 trades over 2026-09-10 to 2026-09-11.
1 min readOpaleye Management Inc. purchased 9,976 indirectly-held shares of Sol-Gel Technologies Ltd. (SLGL) at an average of $68.88 ($68.70–$69.52, $0.69M total) across 5 trades over 2026-09-04 to 2026-09-09.
1 min readOpaleye Management Inc. purchased 1,683 indirectly-held shares of Sol-Gel Technologies Ltd. (SLGL) at an average of $69.21 ($68.95–$69.52, $0.12M total) across 2 trades over 2026-09-01 to 2026-09-02.
1 min readOpaleye Management Inc. purchased 40,330 indirectly-held shares of Sol-Gel Technologies Ltd. (SLGL) at an average of $69.19 ($68.24–$71.40, $2.79M total) across 5 trades over 2026-08-28 to 2026-08-31.
1 min readSol-Gel Technologies Ltd. (SLGL) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates • Pivotal Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome remains ongoing, with top-line results on track for anticipated readout in late November 2026 • So
2 min readOpaleye Management Inc. purchased 951 indirectly-held shares of Sol-Gel Technologies Ltd. (SLGL) at $71.50 on 2026-08-12.
2 min readBiotech stocks rose as several companies issued updates. Wellgistics Health (WGRX) completed a rebrand to DataMEDS AI and will trade as MEDS; it reported Q1 2026 revenue of $0.929M and expects $1.775M in Q2. Dyadic (DYAI) saw a major shareholder sell. Palvella (PVLA) submitted the first NDA module for QTORIN. Sol-Gel (SLGL) expects SGT-610 Phase 3 data in Q4 2026.
6 min readOpaleye Management Inc. purchased 1,695 indirectly-held shares of Sol-Gel Technologies Ltd. (SLGL) at an average of $73.64 ($73.43–$73.89, $0.12M total) across 2 trades over 2026-07-13 to 2026-07-14.
2 min readOpaleye Management Inc. purchased 529 indirectly-held shares of Sol-Gel Technologies Ltd. (SLGL) at an average of $73.80 ($73.69–$73.95) across 2 trades over 2026-07-08 to 2026-07-10.
2 min readOpaleye Management Inc. purchased 1,712 indirectly-held shares of Sol-Gel Technologies Ltd. (SLGL) at an average of $71.97 ($71.97–$71.99, $0.12M total) across 2 trades over 2026-07-01 to 2026-07-02.
3 min read